Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest Profit Margin

Below are the top diagnostic substances stocks on the NASDAQ in terms of profit margin. The trailing-twelve-month profit margin at Trinity Biotech plc

is 20.71%. Trinity Biotech's revenue for the same period is $81.70 million. The trailing-twelve-month profit margin at Meridian Bioscience

is 19.23%. Meridian Bioscience's ROA for the same period is 19.85%. The trailing-twelve-month profit margin at IDEXX Laboratories

is 13.50%. IDEXX Laboratories' ROE for the same period is 28.74%. The trailing-twelve-month profit margin at Neogen

is 12.78%. Neogen's PEG ratio is 2.19.